Perspective Therapeutics
CATX
49 hedge funds and large institutions have $9.99M invested in Perspective Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 4 closing their positions.
0.12% more ownership
Funds ownership: 1.18% → 1.3% (+0.12%)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
2% less funds holding
Funds holding: 50 → 49 (-1)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
55% less capital invested
Capital invested by funds: $22M → $9.99M (-$12M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.48M |
| 2 |
Jane Street
New York
|
+$62.8K |
| 3 |
HF
HRT Financial
New York
|
+$47.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIC
Portland Investment Counsel
Burlington,
Ontario, Canada
|
-$683K |
| 2 |
BlackRock
New York
|
-$373K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$111K |
| 4 |
Renaissance Technologies
New York
|
-$32.3K |
| 5 |
Cerity Partners
New York
|
-$26.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Citadel Advisors
Miami,
Florida
| – | -$111K | -16,678 | Closed |
|
|
52
Cerity Partners
New York
| – | -$26.7K | -4,000 | Closed |
|
53
Osaic Holdings
Scottsdale,
Arizona
| – | -$63 | -10 | Closed |
|
CATX Hedge Fund Activity: Q3 2023 in Review
49 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2023, worth a combined $9.99M — down 55% from $22M a quarter earlier.
Fund positioning in CATX was balanced in Q3 2023: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 12 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $2.48M. The largest seller was Portland Investment Counsel, exiting entirely with an estimated $683K sold.
- 49 institutional investors held Perspective Therapeutics (CATX) as of Q3 2023, down from 50 in Q2 2023.
- Funds reported $9.99M of Perspective Therapeutics stock for Q3 2023, down 55% quarter-over-quarter.
- 4 funds opened new Perspective Therapeutics positions in Q3 2023 and 4 closed out, a net change of 0 holders.
- The largest Perspective Therapeutics buyer in Q3 2023 was Baker Bros. Advisors, an estimated $2.48M added.
- The largest Perspective Therapeutics seller in Q3 2023 was Portland Investment Counsel, an estimated $683K sold.
Based on aggregated 13F filings for Q3 2023.